Dr Reddy's Laboratories Shares Outstanding 2010-2024 | RDY

Dr Reddy's Laboratories shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Dr Reddy's Laboratories shares outstanding for the quarter ending September 30, 2024 were 4.170B, a 400.52% increase year-over-year.
  • Dr Reddy's Laboratories 2024 shares outstanding were 0.834B, a 0.19% increase from 2023.
  • Dr Reddy's Laboratories 2023 shares outstanding were 0.832B, a 0.03% increase from 2022.
  • Dr Reddy's Laboratories 2022 shares outstanding were 0.832B, a 0.01% increase from 2021.
Dr Reddy's Laboratories Annual Shares Outstanding
(Millions of Shares)
2024 834
2023 832
2022 832
2021 832
2020 830
2019 831
2018 831
2017 835
2016 855
2015 852
2014 855
2013 856
2012 878
2011 827
2010 1,200
2009 850
Dr Reddy's Laboratories Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 4,170
2024-06-30 835
2024-03-31 834
2023-12-31 834
2023-09-30 833
2023-06-30 855
2023-03-31 832
2022-12-31 832
2022-09-30 832
2022-06-30 833
2022-03-31 832
2021-12-31 830
2021-09-30 832
2021-06-30 837
2021-03-31 832
2020-12-31 847
2020-09-30 832
2020-06-30 837
2020-03-31 830
2019-12-31 828
2019-09-30 830
2019-06-30 828
2019-03-31 831
2018-12-31 831
2018-09-30 830
2018-06-30 838
2018-03-31 831
2017-12-31 829
2017-09-30 829
2017-06-30 750
2017-03-31 835
2016-12-31 830
2016-09-30 831
2016-06-30 864
2016-03-31 855
2015-12-31 855
2015-09-30 855
2015-06-30 845
2015-03-31 847
2014-12-31 858
2014-09-30 861
2014-06-30 852
2014-03-31 851
2013-12-31 847
2013-09-30 846
2013-06-30 763
2013-03-31 875
2012-12-31 863
2012-09-30 770
2012-06-30 750
2012-03-31 850
2011-12-31 808
2011-09-30 788
2011-06-30 843
2011-03-31 938
2010-12-31 763
2010-09-30 800
2010-06-30 750
2010-03-31 925
2009-12-31 800
2009-09-30 750
2009-06-30 845
2009-03-31 873
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $11.978B $3.350B
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00